COX1 and COX2 polymorphisms and gastric cancer risk in a polish population

Anticancer Research

Volumn 27, Issue 6 C, 2007, Pages 4243-4247

  Hou, Lifang ^a   Grillo, Paolo ^b   Zhu, Zhong Zheng ^c   Lissowska, Jola ^d   Yeager, Meredith ^e   Zatonski, Witold ^d   Zhu, Guanshan ^f   Baccarelli, Andrea ^b,g   Chanock, Stephen J ^e   Fraumeni Jr , Joseph F ^e   Chow, Wong Ho ^e  

^a NORTHWESTERN UNIVERSITY   (United States)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^c No 113 Hospital of People's Liberation Army   (China)

^d INSTITUTE OF ONCOLOGY   (Poland)

^e NATIONAL CANCER INSTITUTE   (United States)

^f Shanghai GenePharma Co Ltd   (China)

^g UNIVERSITY OF MILAN   (Italy)

Author keywords

COX1; COX2; Gastric cancer; Polymorphisms

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2;

ARTICLE; CANCER RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; GENE IDENTIFICATION; GENOTYPE; HUMAN; PRIORITY JOURNAL; STOMACH CANCER;

ADULT; AGED; CASE-CONTROL STUDIES; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; POLAND; POLYMORPHISM, SINGLE NUCLEOTIDE; STOMACH NEOPLASMS;

EID: 37549010968     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Dai Y and Wang WH: Non-steroidal anti-inflammatory drugs in prevention of gastric cancer. World J Gastroenterol 12: 2884-2889, 2006.
2. Wang WH, Huang JQ, Zheng GF, Lam SK, Karlberg J and Wong BC: Non-steroidal anti-inflammatory drug use and the risk of gastric cancer: a systematic review and meta-analysis. J Natl Cancer Inst 95: 1784-1791, 2003.
3. Moran EM: Epidemiological and clinical aspects of nonsteroidal anti-inflammatory drugs and cancer risks. J Environ Pathol Toxicol Oncol 21: 193-201, 2002.
4. Smith WL, Garavito RM and DeWitt DL: Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2. J Biol Chem 271: 33157-33160, 1996.
5. Uefuji K, Ichikura T and Mochizuki H: Cyclooxygenase-2 expression is related to prostaglandin biosynthesis and angiogenesis in human gastric cancer. Clin Cancer Res 6: 135-138, 2000.
6. Murata H, Kawano S, Tsuji S, Tsuji M, Sawaoka H, Kimura Y, Shiozaki H and Hori M: Cyclooxygenase-2 overexpression enhances lymphatic invasion and metastasis in human gastric carcinoma. Am J Gastroenterol 94: 451-455, 1999.
7. Ohno R, Yoshinaga K, Fujita T, Hasegawa K, Iseki H, Tsunozaki H, Ichikawa W, Nihei Z and Sugihara K: Depth of invasion parallels increased cyclooxygenase-2 levels in patients with gastric carcinoma. Cancer 91: 1876-1881, 2001.
8. Sun WH, Yu Q, Shen H, Ou XL, Cao DZ, Yu T, Qian C, Zhu F, Sun YL, Fu XL and Su H: Roles of Helicobacter pylori infection and cyclooxygenase-2 expression in gastric carcinogenesis. World J Gastroenterol 10: 2809-2813, 2004.
9. Langsenlehner U, Yazdani-Biuki B, Eder T, Renner W, Wascher TC, Paulweber B, Weitzer W, Samonigg H and Krippl P: The cyclooxygenase-2 (PTGS2) 8473T>C polymorphism is associated with breast cancer risk. Clin Cancer Res 12: 1392-1394, 2006.
10. Campa D, Zienolddiny S, Maggini V, Skaug V, Haugen A and Canzian F: Association of a common polymorphism in the cyclooxygenase 2 gene with risk of non-small cell lung cancer. Carcinogenesis 25: 229-235, 2004.
11. Sakoda LC, Gao YT, Chen BE, Chen J, Rosenberg PS, Rashid A, Deng J, Shen MC, Wang BS, Han TQ, Zhang BH, Cohen-Webb H, Yeager M, Welch R, Chanock S, Fraumeni JF Jr and Hsing AW: Prostaglandin-endoperoxide synthase 2 (PTGS2) gene polymorphisms and risk of biliary tract cancer and gallstones: a population-based study in Shanghai, China. Carcinogenesis 27: 1251-1256, 2006.
12. Hu Z, Miao X, Ma H, Wang X, Tan W, Wei Q, Lin D and Shen H: A common polymorphism in the 3′UTR of cyclooxygenase 2/prostaglandin synthase 2 gene and risk of lung cancer in a Chinese population. Lung Cancer 48: 11-17, 2005.
13. Gallicchio L, McSorley MA, Newschaffer CJ, Thuita LW, Huang HY, Hoffman SC and Helzlsouer KJ: Nonsteroidal antiinflammatory drugs, cyclooxygenase polymorphisms, and the risk of developing breast carcinoma among women with benign breast disease. Cancer 106: 1443-1452, 2006.
14. Park JM, Choi JE, Chae MH, Lee WK, Cha SI, Son JW, Kim CH, Kam S, Kang YM, Jung TH and Park JY: Relationship between cyclooxygenase 8473T>C polymorphism and risk of lung cancer: a case-control study. BMC Cancer 6: 70, 2006.
15. Cox DG, Pontes C, Guino E, Navarro M, Osorio A, Canzian F and Moreno V: Polymorphisms in prostaglandin synthase 2/cyclooxygenase 2 (PTGS2/COX2) and risk of colorectal cancer. Br J Cancer 91: 339-343, 2004.
16. Sorensen M, Autrup H, Tjonneland A, Overvad K and Raaschou-Nielsen O: A genetic polymorphism in prostaglandin synthase 2 (8473, T - >C) and the risk of lung cancer. Cancer Lett 226: 49-54, 2005.
17. Shahedi K, Lindstrom S, Zheng SL, Wiklund F, Adolfsson J, Sun J, Augustsson-Balter K, Chang BL, Adami HO, Liu W, Gronberg H and Xu J: Genetic variation in the COX-2 gene and the association with prostate cancer risk. Int J Cancer 119: 668-672, 2006.
18. Liu F, Pan K, Zhang X, Zhang Y, Zhang L, Ma J, Dong C, Shen L, Li J, Deng D, Lin D and You W: Genetic variants in cyclooxygenase-2: Expression and risk of gastric cancer and its precursors in a Chinese population. Gastroenterology 130: 1975-1984, 2006.
19. Zhang X, Miao X, Tan W, Ning B, Liu Z, Hong Y, Song W, Guo Y, Zhang X, Shen Y, Qiang B, Kadlubar FF and Lin D: Identification of functional genetic variants in cyclooxygenase-2 and their association with risk of esophageal cancer. Gastroenterology 129: 565-576, 2005.
20. Zhang XM, Miao XP, Tan W, Sun T, Guo YL, Zhao D and Lin DX: Genetic polymorphisms in the promoter region of cyclooxygenase-2 and their association with risk of gastric cancer. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 28: 119-123, 2006 [in Chinese].
21. Panguluri RC, Long LO, Chen W, Wang S, Coulibaly A, Ukoli F, Jackson A, Weinrich S, Ahaghotu C, Isaacs W and Kittles RA: COX-2 gene promoter haplotypes and prostate cancer risk. Carcinogenesis 25: 961-966, 2004.
22. Koh WP, Yuan JM, van den Berg D, Lee HP and Yu MC: Interaction between cyclooxygenase-2 gene polymorphism and dietary n-6 polyunsaturated fatty acids on colon cancer risk: the Singapore Chinese Health Study. Br J Cancer 90: 1760-1764, 2004.
23. Hamajima N, Takezaki T, Matsuo K, Saito T, Inoue M, Hirai T, Kato T, Ozeki J and Tajima K: Genotype frequencies of cyclooxygenease 2 (COX2) rare polymorphisms for Japanese with and without colorectal cancer. Asian Pac J Cancer Prev 2: 57-62, 2001.
24. Goodman JE, Bowman ED, Chanock SJ, Alberg AJ and Harris CC: Arachidonate lipoxygenase (ALOX) and cyclooxygenase (COX) polymorphisms and colon cancer risk. Carcinogenesis 25: 2467-2472, 2004.
25. El-Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, Young HA, Herrera J, Lissowska J, Yuan CC, Rothman N, Lanyon G, Martin M, Fraumeni JF Jr and Rabkin CS: Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 404: 398-402, 2000.
26. Chow WH, Swanson CA, Lissowska J, Groves FD, Sobin LH, Nasierowska-Guttmejer A, Radziszewski J, Regula J, Hsing AW, Jagannatha S, Zatonski W and Blot WJ: Risk of stomach cancer in relation to consumption of cigarettes, alcohol, tea and coffee in Warsaw, Poland. Int J Cancer 81: 871-876, 1999.
27. Lan Q, Chow WH, Lissowska J, Hein DW, Buetow K, Engel LS, Ji B, Zatonski W and Rothman N: Glutathione S- transferase genotypes and stomach cancer in a population-based case-control study in Warsaw, Poland. Pharmacogenetics 11: 655-661, 2001.
28. Packer BR, Yeager M, Burdett L, Welch R, Beerman M, Qi L, Sicotte H, Staats B, Acharya M, Crenshaw A, Eckert A, Puri V, Gerhard DS and Chanock SJ: SNP500Cancer: a public resource for sequence validation, assay development, and frequency analysis for genetic variation in candidate genes. Nucleic Acids Res 34: D617-621, 2006.
29. Barrett JC, Fry B, Maller J and Daly MJ: Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263-265, 2005.
30. Zavros Y, Rathinavelu S, Kao JY, Todisco A, Del Valle J, Weinstock JV, Low MJ and Merchant JL: Treatment of Helicobacter gastritis with IL-4 requires somatostatin. Proc Natl Acad Sci USA 100: 12944-12949, 2003.
31. Ristimaki A, Honkanen N, Jankala H, Sipponen P and Harkonen M: Expression of cyclooxygenase-2 in human gastric carcinoma. Cancer Res 57: 1276-1280, 1997.